Horm Metab Res 2003; 35(2): 104-108
DOI: 10.1055/s-2003-39052
Original Clinical
© Georg Thieme Verlag Stuttgart · New York

Dehydroepiandrosterone Metabolism in Human Plasma

F.  Albo 1, 2 , M.  L.  Barbaccia 1 , A.  Cavazza 1 , M.  Marini 1 , L.  G.  Roda 1
  • 1 Dipartimento di Neuroscienze, Università degli Studi di Roma Tor Vergata, Rome, Italy
  • 2 Istituto di Chimica e Chimica Clinica, Università Cattolica del Sacro Cuore, Rome, Italy
Further Information

Publication History

Received 26 March 2002

Accepted after revision 26 September 2002

Publication Date:
07 May 2003 (online)

Abstract

The possibility that dehydroepiandrosterone (DHEA) is metabolized in human plasma was studied by column and thin-layer chromatography. The results obtained indicate that a time-dependent disappearance of DHEA is matched by the appearance of newly-formed species that may represent DHEA conversion by-products. Neither disappearance of DHEA, nor formation of the alleged conversion by-products was observed when reactions were performed under conditions in which plasma enzymes were removed or inactivated. These results suggest that, in plasma, DHEA is partially transformed into different substances, and that the conversion reactions are catalyzed by enzymes present in this tissue. The observed kinetics of appearance and partial disappearance of the radiolabeled species can be interpreted as indicating that some of the by-products formed are further converted into other substances. The data shown appear to indicate that plasma can be added to the list of the already known compartments that are involved in steroid metabolism.

References

  • 1 Labrie F, Luu-The V, Lin S X, Simard J, Labrie C, El-Alfy M, Pelletier G, Belanger A. Intracrinology: role of the family of hydroxysteroid-dehydrogenases in human physiology and disease.  J Mol Endocrinol. 2000;  25 1-16
  • 2 Rosenfeld R S, Hellman L, Gallagher T F. Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate.  J Clin Endocrinol Metab. 1972;  35 187-193
  • 3 Canonaco M, Andò S, Valenti A, Tavolaro R, Panno M L, Maggiolini M, Dessì-Fulgheri F. The in-vitro transformation of [3H] dehydroepiandrosterone into its principal metabolites in the adrenal cortex of adult castrated male rats and following steroid treatment.  Endocrinology. 1989;  121 419-424
  • 4 Zhou Z, Agarwal V, Dixit N, White P, Speiser P W. Steroid 21-hydroxylase expression and activity in human lymphocytes.  Mol Cell Endocrinol. 1997;  127 11-18
  • 5 Schmidt M, Kreutz M, Loffler G, Scholmerich J, Straub R H. Conversion of dehydroepiandrosterone to downstream hormones in macrophages.  J Endocrinol. 2000;  164 161-169
  • 6 Meikle A W, Dorchuck R W, Araneo B A, Stringham J D, Evans T G, Spotswood L S, Daynes R A. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells.  J Steroid Biochem Mol Biol. 1992;  42 293-304
  • 7 Daynes R A, Dudley D J, Araneo B A. Regulation of murine lymphokine production in vivo, II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells.  Eur J Immunol. 1990;  20 793-808
  • 8 Hennebold J D, Daynes R A. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines.  Endocrinology. 1994;  135 67-75
  • 9 Bird C E, Murphy J, Boroomand K, Finnis W, Dressel D, Clark A F. Dehydroepiandrosterone: kinetics of metabolism in normal men and women.  J Clin Endocrinol Metab. 1978;  818-822
  • 10 Longcope C. Dehydroepiandrosterone metabolism.  J Endocrinol. 1996;  150 S125-S127
  • 11 Barbaccia M L, Lello S, Sidiropoulou T, Cocco T, Sorge R P, Cocchiarale A, Piermarini V, Sabato A F, Trabucchi M, Romanini C. Plasma 5-α-androstane-3α-17β-diol, an endogenous steroid that positively modulates GABA receptor function, and anxiety: a study in menopausal women.  Psychoneuroendocrinology. 2000;  25 659-675
  • 12 Legrain S, Massien C, Lahlou N, Roger M, Debuire B, Diquet B, Chatellier G, Azizi M, Faucounau V, Porchet H, Forette F, Baulieu E-E. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.  J Clin Endocrinol Metab. 2000;  85 3208-3217
  • 13 Wang D Y, Bulbrook R D, Sneddon A, Hamilton T. The metabolic clearance rates of dehydroepiandrosterone, testosterone, and their sulphate esters in man, rat, and rabbit.  J Endocrinol. 1967;  38 307-318
  • 14 Majewska M D, Harrison N L, Schwartz R D, Barker J L, Paul S M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.  Science. 1986;  323 1004-1007
  • 15 Roda L G, Roscetti G, Venturelli F, Vita F. Control mechanisms in the enzyme hydrolysis of adrenal-released enkephalins. In: Plotnikoff NP, Murgo AJ, Faith RE, Good R (eds) Enkephalins and Endorphins: Stress and the Immune System. New York; Plenum Publishing Co 1986: 17-33
  • 16 Buzzetti R, McLoughlin L, Scavo D, Rees L H. A critical assessment of the interactions between the immune system and the hypothalamo-pituitary-adrenal axis.  J Endocrinol. 1989;  120 183-187

L. G. Roda

Dipartimento di Neuroscienze

Università degli Studi di Roma Tor Vergata · Via Montpellier 1 · 00133 Roma · Italia

Email: lgroda@libero.it